Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials
<p><strong>Objectives:</strong> To assess the efficacy and safety of methotrexate (MTX) in combination with an approved biological agent compared to biological monotherapy, in the management of patients with rheumatoid arthritis (RA).</p> <p><strong>Methods:</s...
Main Authors: | Tarp, S, Jørgensen, TS, Furst, DE, Dossing, A, Taylor, PC, Choy, EH, Suarez-Almazor, ME, Lyddiatt, A, Kristensen, LE, Bliddal, H, Christensen, R |
---|---|
Format: | Journal article |
Published: |
Elsevier
2018
|
Similar Items
-
Biologic monotherapy in the treatment of rheumatoid arthritis
by: Detert J, et al.
Published: (2015-05-01) -
Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
by: Taylor, P, et al.
Published: (2022) -
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
by: Tanja Schjødt Jørgensen, et al.
Published: (2017-01-01) -
Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project.
by: Gil Amarilyo, et al.
Published: (2016-01-01) -
Biological agents in monotherapy for the treatment of rheumatoid arthritis
by: Cem Gabay, et al.
Published: (2014-04-01)